BPC-157

Product

Heard on podcasts recently

An experimental peptide studied primarily in preclinical research for tissue repair, inflammation, and angiogenesis; it is not an FDA-approved general medical treatment.

Rank this week

—
Not in this week’s list

Share of the conversation

—

Reach this week

—

Tone this week

—

Not enough signal yet (fewer than 3 episodes scored).

Share of the conversation

Mentions of BPC-157 per 1,000 mentions of anything, 7-day rolling, all podcasts.

0.0‰0.05‰0.1‰0.15‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Aug 260.03‰1
Sep 10.04‰3
Sep 30.08‰5
Sep 40.09‰1
Sep 80.08‰1
Sep 100.07‰4
Sep 120.07‰2
Sep 140.09‰2
Sep 190.03‰1
Sep 220.02‰1
Sep 280.03‰2
Sep 290.03‰1
Oct 40.04‰1
Oct 50.03‰1
Oct 100.03‰1
Oct 160.06‰6
Oct 180.06‰1
Oct 200.08‰2
Oct 220.09‰2
Oct 270.02‰1
Oct 290.03‰2
Nov 60.01‰1
Nov 130.01‰1
Nov 180.02‰1
Nov 200.02‰1

Who is saying what about BPC-157

Verified quotes from the last 90 days: who made the most claims, and which way they leaned.

Discussed alongside

Names that come up in the same conversations as BPC-157.

See 5 more with Pro

Embed this

Paste this on your site to show BPC-157's current trend:

<iframe src="https://podlume.ai/embed/e/product-bpc-157" width="360" height="220" style="border:0" loading="lazy" title="BPC-157 on PodLume Trends"></iframe>